Nearly half of all women have "dense breasts"—yet countless don't find out until later in life. Dense breasts have more fibrous and glandular tissue relative to fat tissue in the breast. Because both breast cancer and this breast tissue appear white on mammograms, those mammograms alone can miss up to 60% of cancers in dense breasts.
JoAnn Pushkin, patient advocate and co-founder of DenseBreast-info.org, lived through this exact scenario. "My own cancer was missed for nearly five years in a row," she says. "During that time, I received a 'normal' mammogram report every one of those years. The cancer was present, but because my breasts were so dense, the cancer could not be seen. The day my cancer was big enough to feel, it still did not show up on a mammogram."
Dense breasts are not something you can see or feel, explains Bonnie Litvack, MD, diagnostic radiologist at Northwell Health. Density has nothing to do with breast size or firmness. It is genetic, like hair or eye color. Dense breast tissue not only makes mammograms more difficult to read, but it is also a risk factor for breast cancer. Women with dense breasts have a higher risk of developing breast cancer than women who don't have dense breasts, Litvack says. Density can also vary over a woman's lifetime, mostly due to hormonal changes, hormone replacement therapy, pregnancy, and breastfeeding. This is why women need access to advanced screening tools in addition to mammograms—and why those tools need to be universally covered by insurance, Litvack and Pushkin say.
In 2023, the FDA published a rule stating that mammogram reports sent to patients must include breast density, which should be described as either "not dense" or "dense." It took effect on Sept. 10, 2024. "[The new legislation] is a really great thing. We're happy about this," Litvack says, but it's not enough. Once women know they have dense breasts, they need to be able to get additional screening, such as an ultrasound or MRI, to help ensure cancer is caught.
Nationally, insurance coverage for additional screening after a mammogram is inconsistent and can depend on a woman's insurance policy, her insurer, and state law. Without coverage for supplemental screening, "women are being left out in the cold," Pushkin says. "Women write to us all the time with insurance questions, often denials of supplemental screening."
Surprisingly, this gap exists around the country in part because doctors fear more false-positive breast cancer screenings. More screening may include false positives, Pushkin acknowledges, adding "You will never die from a false positive—but you can die from a false negative. It is a small price to pay for the chance to find cancer at the earliest stage possible."
Dense breasts are extremely common, and women are already being notified if they have them—now they need to be able to do something about it. It's critical that we:
Supplemental screening can improve women's chances of detecting cancer early. Physicians and legislators can help ensure women get the mammograms and supplemental screenings they need.
"Information empowers," Pushkin says. "Give women the information to make the best decisions for themselves."
This story was produced by Northwell Health and reviewed and distributed by Stacker.